Aggregatibacter actinomycetemcomitans is a Gram-negative bacterium that is part of the oral microbiota. The aggregative nature of this pathogen or pathobiont is crucial to its involvement in human disease. It has been cultured from non-oral infections for more than a century, while the portrayal as an aetiological agent in periodontitis has emerged more recently. Although A.
Introduction
Aggregatibacter actinomycetemcomitans is the type species of genus Aggregatibacter, which is part of bacterial family Pasteurellaceae. [Bacterium actinomycetem comitans] was cultured from actinomycotic lesions of humans in the early 20 th century. The absence of related microorganisms rendered it difficult to classify this Gram-negative, fastidious rod, and isolates cultured from invasive infections were referred to national reference institutions. The expanding field of oral microbiology with focus on periodontitis, particularly the initially localized, severe form that affects adolescents, caused a renewed interest in the bacterium, and several putative virulence factors and toxins were described. In 2006, the current species name was adopted, and A. actionomycetemcomtians became type species of a new bacterial genus, Aggregatibacter. Seminal events in the chronicle of A. actinomycetemcomitans are listed in Table 1 .
Table 1. Seminal events in the history of Aggregatibacter actinomycetemcomitans
A. actinomycetemcomitans is one species among a plethora of microorganisms that constitute the oral microbiota. It was previously estimated that about 500 species of bacteria inhabit the oral cavity [13] [14] [15] , and because of significant effort expended to cultivate oral bacteria it is thought that about 50% of oral bacteria have been cultivated. Analysis of a large number of 16S rRNA gene clones from studies of the oral microbiota increased the number of taxa to 619 [16] , and the number is steadily increasing (www.homd.org). Bacterial species cannot be validly named in the absence of a cultured type strain [17] . Although "taxa", "phylotypes" or "operative taxonomic units" revealed by deep sequencing of 16S rRNA have relevance for the recognition of microbial fluctuations in health and disease, only cultivable microbiota can be made subject to extensive characterisation, including adherence, animal experiments, antimicrobial susceptibility, co-culture, generation of mutants, and growth characteristics. [3] 1976 [Actinobacillus actinomycetemcomtians] is associated with periodontitis in adolescents [4, 5] 1979 Extraction and partial characterisation of Ltx, a leukotoxin capable of specific lyse of human polymorphonuclear leukocytes [6] 1982 The HACEK group of fastidious, Gram-negative bacteria causing infective endocarditis, is conceived [7] 1982 Serum antibody levels links [Actinobacillus actinomycetemcomtians] with localised juvenile periodontitis [8] 1983 Three distinct surface antigens are identified and a particularly high periodontopathogenic potential of serotype b is indicated [9] 1994 The 530-bp deletion in the ltx promoter region is associated with enhanced expression of Ltx and becomes a marker for the so-called JP2 clone of Actinobacillus actinomycetemcomitans [10] 2006 A new bacterial genus, Aggregatibacter is created with Aggregatibacter actinomycetemcomitans being the type species [11] 2008 Clinical follow-up studies unequivocally demonstrate that carriage of the JP2 clone is linked with aggressive periodontitis [12] 4 Carriage of A. actinomycetemcomitans appears to be highly host-specific. Although spread and dissemination of bacterial clones occur, it is not a frequent event; hosts tend to carry their strain from teething to edentulous old age [18] . Yet, the species encompasses properties that sometimes reveal its significance in human disease. Particularly, a single serotype b clonal lineage is associated with a silent, but aggressive disease that results in periodontitis and tooth loss in adolescents of African heritage [12] . But rather than being the causative agent of aggressive periodontitis, A.
actinomycetemcomitans may be necessary for the action of a consortium of bacterial partners by suppressing host defences [19] . It may be classified as a low abundance oral pathobiont, defined as a member of the microbiota that exerts specific effects on the host's mucosal immune system significantly higher in the US [33, 34] .
An initial characterization of the population structure of the species was published in 1994, using multi-locus enzyme electrophoresis [35] . Two large and four small divisions were identified, with respectively [36] .
One study attempted to establish a multi-locus sequence typing (MLST) scheme for A.
actinomycetemcomitans [37] . Six gene fragments from the Haemophilus influenzae MLST scheme were used. The investigation focused on the JP2 clone, which contributed 66 of 82 strains. MLST has insufficient power to reveal dissemination patterns of clonally related strains, and point mutations of two pseudogenes present in the JP2 clone were more versatile in this respect [37] .
Moreover, a MLST web site was not organised, and therefore the benefits of a portable typing 7 scheme were not corroborated. But MLST of 16 strains carefully selected from the enzyme electrophoresis study [35] suggested the existence of four phylogenetic clusters, rooted by an outgroup consisting of an uncommon St(e) strain. Two related clusters were composed of St(b) and
St(c) strains, respectively, while a more distinct cluster encompassed strains of St(a), St(d) and St(e) [37] .
Restriction fragment length polymorphism using various restriction enzymes and arbitrarilyprimed PCR has been used to differentiate types of A. actinomycetemcomitans cultured from patients with juvenile periodontitis and healthy controls [30, [37] [38] [39] [40] [41] [42] . The method is versatile and discriminative, but lacks portability and a common nomenclature; thus, it is of value for individual studies of specific strains, but lacks general applicability and taxonomic significance.
Finally, whole genome sequencing has been introduced for characterisation of the species [43-45].
In the largest study, sequences from two human strains of Aggregatibacter aphrophilus, 30 human antigen were highly conserved between clade e and clade e' strains, but e' strains were found to be missing the genomic island that carries genes encoding the cytolethal distending toxin. Moreover, the clade e' strains were more related to an Old-World primate strain and carried the unusual 16S rRNA type V sequence (RNA types as defined by Kaplan et al. [36] figurative, but more knowledge on the new lineage III is needed to disclose the relevance for phenotype, host specificity and pathogenicity. Clinical isolate incubated on TSBV (tryptic soy-serum-bacitracin-vancomycin) agar for 4 days in 5% CO2. Expression of the distinctive, "star-shaped" colony is facilitated by growth on TSBV agar.
General Characteristics
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Recovery, Phenotype, and Molecular Detection
Relevant sites in the oral cavity for sampling of A. actinomycetemcomitans are periodontal pockets, the mucosa, and saliva. Sampling techniques include use of sterile paper points to be inserted in periodontal pockets, cotton swab for the mucosa, and spitting for the collection of stimulated saliva. For transport of paper points, the VMGAIII-medium is recommended [49] .
Samples collected with cotton swap can be transported in a salt buffer [50] or in TE-buffer. Saliva can be transported in tubes without additives.
The selective medium TSBV (tryptic soy-serum-bacitracin-vancomycin) agar [51] is commonly used for culture. If Enterobacterales are present in significant amounts in the samples, a modified version of TSBV is recommended [52] . Detection of A. actinomycetemcomitans in clinical samples renders limited information on prediction, progression, and treatment planning of periodontal disease. For these purposes, the proportion of the bacterium at diseased sites is more relevant. This is in line with the ecological plaque hypothesis [53] . Detection level of A. actinomycetemcomitans is around 100 viable bacteria (colony-forming units) per mL. Fusobacterium nucleatum and other strict anaerobes will grow on TSBV in the absence of oxygen. The total concentration of viable bacteria is estimated by parallel cultivation on 5% blood agar plates, and the proportion of A.
actinomycetemcomitans in the sample can be calculated.
A. actinomycetemcomitans is suspected when rough-textured, tenacious colonies appear on selective agar after one or two days ( Figure 2 ). The species is distinguished from closely related bacteria by a positive catalase reaction and negative β-galactosidase reaction. Salient biochemical characters of A. actinomycetemcomitans have been published [54] . In addition, the bacterium is readily identified by MALDI-TOF mass spectrometry [55] ; however, the current version of the Bruker database (v3.1) only includes mass spectra from a limited number of strains, and modest log-scores are not unusual when clinical strains are examined.
Leukotoxicity, i.e., the capacity of the bacterium to kill or inactivate immune cells, is properly determined in biological assays involving human cell lines [56] , but a semi-quantitative method based on hemolysis on blood agar plates has been reported [42, 57] . Quantification of the leukotoxin by ELISA is also used; most studies have assessed the leukotoxin released from the surface of the bacterium, either during growth in broth [58] , or by treatment of bacteria cultured in media that inhibit leukotoxin release with a hypertonic salt solution [42] . Leukotoxicity may also be estimated by determination of the total amount of leukotoxin produced by the strain. Bacterial suspensions are solubilized by SDS, and the leukotoxin is subsequently quantitated by Western blot-based methodology. It is anticipated that the amount of leukotoxin released from the bacterial cell surface reflects the total amount of leukotoxin produced, but this relationship remains to be corroborated.
For identification of A. actinomycetemcomitans in clinical samples by PCR, DNA is purified manually or by using a Robot. Samples can be stored at -20 o C or mixed with DNA preserving buffer and stored at room temperature. An improved method for PCR-based detection of leukotoxin promoter was described [59] . This method discriminates the JP2 genotype of A.
actinomycetemcomitans from other strains, but because of preferential amplification of smaller products, the method is more sensitive for the JP2 genotype. For PCR-based quantification, the methods described by Kirakodu et al. [60] and Yoshida et al. [61] are recommended. By using the latter method, JP2 and non-JP2 genotypes are separately quantitated. The qPCR machine renders a so-called Cycling Threshold (CT)-value, which is related to the concentration of DNA in the sample, and a standard curve can be established and included in each run on the machine to estimate the concentration of bacteria. To approximate the total number of bacteria by qPCR, the 16S rRNA gene is generally the target. The method can only provide a rough estimate, as primers and probes may preferentially bind to certain bacterial phyla, and because the number of copies of the gene varies substantially between different bacterial species [62] .
Serotypes a through f can be identified by PCR as described [63, 64] . A method for detecting St(g)
has not yet been described.
Aggregative Properties and the Leukotoxin Gene Operon
A. actinomycetemcomitans expresses three potential toxins, fimbriae and a number of adhesins, plus a number of other gene products that may have significance for microbial interplay, persistence, transformation to planktonic state, and pathogenicity ( Table 2) . 
Genomic characteristics and putative virulence determinants of A. actinomycetemcomitans
References
Widespread colonization island or the tad locus [65] Autotransporter adhesins Aae, EmaA and Omp100/ApiA [66] [67] [68] A leukotoxin of the RTX family with specificity for leukocytes [69] Growth-inhibitory factor cytolethal distending toxin [70, 71] CagE, capable of inducing apoptosis [72] Dispersin B, a biofilm-releasing beta-hexosaminidase [73] Vesicle-independent extracellular pelease of proinflammatory lipoprotein [74] The conspicuous growth in broth as small granules adhering to the walls of the test tube was noted in the original description of [Bacterium actinomycetem comitans] [1] . Fresh isolates of A.
actinomycetemcomitans invariably form colonies that are rough-textured with an opaque, starshaped internal structure ( Figure 2B ). Cells from rough colonies grow in broth as granular, autoaggregated cells that adhere to the glass and leave a clear broth. A. actinomycetemcomitans possesses fimbriae, and these appendages can be irreversible lost after prolonged subculture in the laboratory [75] . Antibodies to synthetic fimbrial peptide significantly reduce the binding of A.
actinomycetemcomitans to saliva-coated hydroxyapatite beads, buccal epithelial cells and a fibroblast cell line, indicating a decisive role of these structures for adherence to multiple surfaces [76] . Moreover, autoaggregation (defined as the ability of cells to form aggregates or clumps that settled to the bottom of a liquid broth suspension) was completely lost by a smooth-colony, isogenic variant [77] . Fimbriae are assembled as bundles of 5-to 7-nm-diameter pili composed of a 6.5 kDa protein designated Flp (fimbrial low-molecular-weight protein) [78, 79] . flp-1 is part of a 14-gene locus designated the tad locus. The Tad (tight adherence) macromolecular transport system is a subtype of type II secretion. The tad locus is composed of nine tad, three rcp and two flp genes (65) . The RcpA/B (rough colony proteins) were previously shown to be outer membrane proteins specifically associated with rough colony variants [80] . Mutation analysis of the naturally competent strain D7S revealed flp-1, rcpA, rcpB, tadB, tadD, tadE and tadF to be indispensable for expression of fimbriae, while mutants of five other genes expressed reduced levels of fimbriae, or fimbriae that had different gross appearance [81] . Random or targeted mutagenesis coupled with genetic complementation analysis revealed that at least 12, and probably 13, of the genes in the tad locus are required for Flp-pilus production [65] . flp-2 is not required for any adherence-related phenotypes in A. actinomycetemcomitans and may not be expressed, while mutations in rcpB are lethal to wild-type A. actinomycetemcomitans [82] . In a rat model, the tad locus was critical for colonizing the oral cavity and for pathogenesis, measured as maxillae bone loss and A.
actinomycetemcomitans-specific IgG levels [83] .
Many pathogenic bacteria are capable of phase variation that depends on expression of surface proteins, but smooth-to-rough conversion has not been substantiated for A. actinomycetemcomitans.
Rather, the rough-to-smooth conversion is typically caused by mutations in the flp promoter region, and replacement with wild-type promoter can restore the rough phenotype [84] . However, one study indicated that smooth strains could re-express the fimbriae in low humidity environments [85] .
In addition to expression of fimbriae decisive for autoaggregation and adherence to a wide range of solid surfaces (biofilm formation), A. actinomycetemcomitans encodes a spectrum of autotransporter adhesins, proteins that promote their own transport from the periplasm to the exterior surface of the bacterial outer membrane. A homologue with similarity in the pore-forming domain to that of the monomeric H. influenzae autotransporter, Hap, was detected in the genome of JP2 clone strain HK_1651, and designated Aae. Inactivation of aae in two naturally transformable strains caused a 70% reduction in adhesion to cultured epithelial cells [66] . Aae exhibits specificity for buccal epithelial cells from humans and Old-World primates, and does not bind to human pharyngeal, palatal, tongue, bronchial, or cervical epithelial cells [86] . Two trimeric autotransportes with homology to members of the YadA adhesin/invasin family are identified. Omp100 has also been designated Api (Aggregatibacter putative invasin). E. coli expresses ApiA bound to human collagen type II, III and V and fibronectin. Furthermore, binding to human monolayer cells mediated by ApiA was specific to buccal epithelial cells from humans and Old-World primates, albeit to a lesser extent than AaE [68, 87] . Screening of a large number of individual insertion transposon mutants for changes in the adhesion to collagen and fibronectin identified a single gene, emaA, to encode a direct mediator of collagen adhesion [88] . Collagen predominates in the supporting tissue of cardiac valves, and the trimeric autotransporter adhesin EmaA (extracellular matrix adhesin) is a potential virulence determinant of A. actinomycetemcomitans in infective endocarditis [89] .
Iron is a transition metal utilized by nearly all forms of life for essential cellular processes. The host limits the availability of iron to the invading pathogen through a process termed nutritional immunity [90] . Gram-negative pathogens have evolved mechanisms to obtain iron from heme, beginning with haemolysis. A major category of pore-forming toxins is the RTX family, whose name derives from the characteristic calcium-binding motif that is repeated in the carboxy termini of such proteins [91] . The best-studied RTX haemolysin is HlyA, which is secreted by Escherichia coli, but RTX toxins are produced by a variety of Gram-negative bacteria including family
Pasteurellaceaeit has even been suggested that these toxins originated in the Pasteurellaceae [92] .
In 1977, it was shown that polymorphonuclear leukocytes exposed to supragingival and subgingival bacterial plaque in vitro released lysosomal constituents [93] , and the leukotoxin (Ltx) of A. actinomycetemcomitans was extracted and partially characterised in 1979 [6] . By 1989, the gene was cloned and analysed [94, 95] , and the 530-bp deletion (JP2 genotype) in the ltx promoter associated with enhanced expression of Ltx was subsequently described [10] . The difference between minimally toxic and highly toxic strains were convincingly illustrated in clinical studies from Northern Africa [12] . The significance of the 530-bp deletion may reside in a potential transcriptional terminator spanning 100 bp [58] . The leukotoxin of A. actinomycetemcomitans is highly specific for human and primate white blood cells and has capability to neutralises the local mucosal immune response. However, purified leukotoxin is able to lyse sheep and human erythrocytes in vitro, and beta-haemolysis can be demonstrated on certain media [96] .
In addition to the JP2 genotype characterised by the 530-bp promoter deletion, two other leukotoxin promoter variants have been reported. One genotype is characterised by a slightly enlarged (640-bp) deletion [97] , while the other promoter variant carries an 886-bp insertion sequence [98] . Both these variants produce levels of leukotoxin similar to the JP2 genotype of A. actinomycetemcomitans.
Geographic Dissemination of Specific Genotypes
The JP2 clone of A. actinomycetemcomitans is suggested to have arisen 2,400 years ago in the northern Mediterranean part of Africa [37] . The bacterial clone is endemically present in Moroccan and Ghanaian populations [12, 99] and almost exclusively detected among individuals of African origin [37, 100] . However, among 17 JP2 clone carriers, living in Sweden and identified during during the years from 2000-2014, ten were of Scandinavian heritage [31] . Among six of the identified JP2 clone carriers, three were of Swedish origin. Detection of the JP2 clone of A.
actinomycetemcomitans has not been reported in Asian populations [30, 98, 101, 102] . The Other genotypes of A. actinomycetemcomitans characterised by a highly leukotoxic potential comprise a 640-bp deletion cultured from a host of Ethiopian origin [97] , an 886-bp insertion sequence from a host of Japanese origin [98] , and two strains of serotype c, originating from
Thailand with a JP2-like ltx gene with a 530-bp deletion in the promoter region and with virulence of similar magnitude to the JP2 genotype strains [103] . All of these genotypes were collected from individuals with severe periodontitis.
Prevalence and Clinical Significance
Cultivable A. actinomycetemcomitans is present in at least 10% of periodontally healthy children with primary dentition [104] . An influential publication found carrier rates of 20% for normal juveniles, 36% for normal adults, 50% for adult periodontitis patients, and 90% for juvenile periodontitis patients [105] . Early studies failed to culture the species from edentulous infants [106] [107] , but molecular studies using PCR on unstimulated saliva samples have challenged this association: 37 of 59 completely edentulous infants were positive for A. actinomycetemcomitans, reaching 100% at 12-month of age [108] . Vertical transmission is common. Two studies reported detection rates by culture of 30-60% in children of adult periodontitis patient, and the genotypes of the strains were always identical [109] [110] . A smaller study from Brazil of women with severe chronic periodontitis did not corroborate this finding, as the two culture-positive children carried genotypes that were different from those of their mothers [111] . Horizontal transmission of A.
actinomycetemcomitans can occur, and transmission rates between 14% and 60% between spouses have been estimated [18, 112] . However, members of most families with aggressive periodontitis also harbour additional clonal types of A. actinomycetemcomitans [113] .
Once colonized, it is extremely difficult to suppress A. actinomycetemcomitans below detection levels in patients with periodontitis. Irrespective of periodontal treatment, colonization by the same strain is remarkably stable within subjects for periods of 5 to 12 years, as revealed by restriction fragment length polymorphism or serotyping combined with arbitrarily-primed PCR [40, 114] .
Genomic stability during persistent oral infections has been demonstrated by various techniques, among these genome sequencing of pairs of A. actinomycetemcomitans strains from the same individual, separated by up to 10 years of time [115, 116] .
The natural habitat of A. actinomycetemcomitans is the oral cavity, but A. actinomycetemcomitans can be isolated from a variety of oral as well as non-oral infectious diseases, including endocarditis, bacteraemia, osteomyelitis, arthritis, skin infections, urinary tract infections and various types of abscesses [117] . Characterisation of 52 non-oral strains showed strong similarity to the oral strains [118] , and the portal of entry for systemic infections is usually the oral cavity [119] .
Infective endocarditis
The oral cavity is the only known habitat of A. actinomycetemcomitans, but only a few layers of crevicular epithelial cells separate subgingival bacteria from the parenteral space of the host. Entry into the blood stream has not been quantitated, but incidental introductions may occur during tooth brushing, injuries, chewing of granular matters etc., possibly potentiated by the presence of periodontitis. A. actinomycetemcomitans was originally co-isolated with Actinomyces from actinomycotic lesions [1] , and the association with Actinomyces has been confirmed by case reports of infections in a variety of anatomical localizations. Among Actinomyces species, co-isolation of A.
actinomycetemcomitans appears restricted to Actinomyces israelii [120, 121] .
Infective endocarditis is an infection of the endocardium that is the lining of the interior surfaces of the chambers of the heart. It usually affects the heart valves ( Figure 3A) , where incidental exposure of sub-endothelium tissue during the extensive motion of the valves may serve as a starting point for bacterial adhesion. A. actinomycetemcomitans is part of the so-called HACEK group of fastidious Gram-negative organisms, which is a recognised, but an unusual cause of infective endocarditis responsible for 1.4-3 % of such cases [122, 123] . The group was originally described to encompass Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae [124] . After taxonomic rearrangements, the HACEK acronym can still be used for the group now denoting non-influenzae Haemophilus sp., Aggregatibacter sp., Cardiobacterium sp., E. corrodens, and Kingella sp. [125] . In the HACEK group, A. actinomycetemcomitans is the organism involved most commonly in infective endocarditis [119, 123] , and bacteraemia with A.
actinomycetemcomitans is strongly associated with this particular focus of infection. In a retrospective study of 87 cases of HACEK bacteraemia from New Zealand, the association between HACEK bacteraemia and infective endocarditis varied among bacterial species ranging from 0% (E. corrodens) to 100% (A. actinomycetemcomitans) [126] . The epidemiological and clinical features of infective endocarditis caused by A. actinomycetemcomitans have been reviewed [119] .
The Complex Interplay with Periodontitis
Periodontitis is an inflammatory disease induced by bacteria and is associated with loss of the supporting connective tissue and alveolar bone around teeth [ Figure 3B ] in 1996 [127] . Inclusion of A. actinomycetemcomitans was based on prevalence studies in health and disease, serum antibody levels, and presence of virulence determinants ( Table 1 and 2).
However, more recently, focus have been drawn to the complex interplay between other cultivable and other non-cultivable bacteria in the oral microbiota, as well as to the interplay with the host [16, 48, 128, 129] . Indeed, it has been suggested that A. actinomycetemcomitans conducts its business by concealing itself below the radar of the host mucosal immune defence system, or even being a community activist that suppresses host responses so as to encourage overgrowth of its partners [19] .
The earlier classification of aggressive periodontitis was based mainly on the clinical presentation and was characterized by a rapid loss of periodontal tissue [130] . Recently, a new periodontitis classification scheme has been adopted, in which forms of the disease (previously separated as chronic or aggressive) are now grouped under a single category and further characterised by a multi-dimensional staging and grading system [131, 132] . Staging is primarily dependent on the severity and extent of disease at presentation, as well as on the complexity of disease management. The grading provides an assessment of the risk of progression and attempts to predict response to standard periodontal therapy [131] .
Therapy
Treatment of periodontitis aims to stop the progression of the periodontal lesion and to maximise periodontal health [133] . Mechanical debridement of the biofilm is considered the most effective therapy, which must be combined with a meticulous oral hygiene. If periodontal lesions persist after 3-6 months, a second phase of therapy is planned. A favourable healing potential has been documented for lesions associated with the rapidly progressive, localised periodontitis that affects adolescents [134] . Systemic antibiotics should only be administered as adjunctive therapy in selected cases.
Access surgery and regenerative techniques have been used for periodontitis stage III-IV [131, 133] . The most significant risk factors are non-compliance with regular maintenance care, smoking, high gingival bleeding index, and poor plaque control [135] .
Very different amoxicillin resistance rates have been reported, ranging from 0% in Switzerland [136] , over 33% in Spain [137] to 84% in the United Kingdom [138] . The mechanisms of resistance were not reported. Production of β-lactamase is the most common cause of β-lactam resistance in Gram-negative bacteria, but these enzymes have not been detected in A. actinomycetemcomitans.
The fastidious nature of the bacterium is a challenge for antimicrobial susceptibility testing, and methods and interpretative criteria must be addressed when reports of resistance are evaluated. A recent, meticulous investigation of strains by a series of methods, and including isolates previously reported as resistant, could not confirm the emergence of resistance to β-lactams in A.
actinomycetemcomitans [139] . Thus, there are no convincing evidence for replacement of amoxicillin in the treatment of A. actinomycetemcomitans-associated periodontitis when the use of antimicrobial agents is indicated.
Gram-negative bacteria are generally more susceptible to the cephalosporin-class than the penicillin-class of β-lactams. For infective endocarditis, an intravenous course of at least four weeks with a third-generation cephalosporin, or a combination of ampicillin and an aminoglycoside, is recommended [119] . Recently, a well-designed randomised clinical study reported favourable outcomes for partial oral antimicrobial therapy regimens given to patients with staphylococcal, streptococcal and enterococcal infective endocarditis deemed clinically stable and without complications [140] . A. actinomycetemcomitans could be a candidate microorganism for use of partial oral antimicrobial treatment of infective endocarditis, but the relative rare occurrence of HACEK bacteraemia poses difficulties for randomised clinical studies.
Conclusions
Cultivable A. actinomycetemcomitans is usually detected if adolescents present with aggressive periodontitis. Its participation in the disease process may be beyond doubt, but its performance in aggressive periodontitis continues to be fascinating and disputed. Adhesion, aggregation and leukotoxic features are well-described, but interplay with other members of the oral microbiota is more difficult to display, as is the interchangeable position of eliciting antibody response and "staying under the radar". The recent division into three subspecies or lineages has not been investigated by clinical studies linking disease and lineage. Disease-specific treatment options are currently widely accepted. 
